Quantcast

Latest Probuphine Stories

2014-09-24 08:28:08

95 of 180 Patients Enrolled; Additional Patients Screened, Awaiting Randomization PRINCETON, N.J., Sept.

2010-11-17 06:00:00

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2010 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (OTC Bulletin Board: TTNP) today announced that data from its Phase 3 clinical development program for Probuphine were presented at the Society for Neuroscience Annual Meeting, being held Nov. 13-17 in San Diego.

2010-11-15 06:00:00

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc.

2010-10-12 18:49:14

Titan Pharmaceuticals, Inc. (TTNP.OB) today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA).

2010-10-12 15:00:00

SOUTH SAN FRANCISCO, Calif., Oct. 12 /PRNewswire/ -- Titan Pharmaceuticals, Inc.

2010-08-16 07:00:00

SOUTH SAN FRANCISCO, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc.

2010-08-03 06:00:00

SOUTH SAN FRANCISCO, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc.

2010-03-30 17:00:00

SOUTH SAN FRANCISCO, Calif., March 30 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction.


Word of the Day
pudic
  • Easily ashamed, having a strong sense of shame; modest; chaste.
  • Of or pertaining to the external organs of generation.
The word 'pudic' comes from French pudique, from Latin pudīcus, from pudet ("it shames"). (Wiktionary)
Related